Intravenous Therapy and Vein Access Devices Market Worth $28 Billion By 2023: Acumen Research and Consulting Print E-mail
By GLOBE NEWSWIRE   
Tuesday, 26 December 2017 23:46

PUNE, India, Dec. 27, 2017 (GLOBE NEWSWIRE)

PUNE, India, Dec. 27, 2017 (GLOBE NEWSWIRE) -- Acumen Research and Consulting, a global provider of market research studies, in a recently published report titled “Intravenous Therapy and Vein Access Devices Market (Product Type: Implantable Port, Intravenous Catheter, Hypodermic Needles, Infusion Pumps, Other Products; Medical Application: Medication Administration, Volume Expanders, Blood Based Products, Nutrition and Buffer Solution; End User: Hospitals, Ambulatory Surgical Centers, Clinics) – Global Industry Analysis, Market Size, Opportunities and Forecast 2023”, estimates that the global market for intravenous therapy and vein access devices is expected to reach the market value of around $28 billion by 2023 and is expected to grow at a CAGR of around 6.4% during the period 2017 - 2023. Owing to the rapidly growing geriatric population, rising incidences of trauma cases and

road mishaps and

Error. Page cannot be displayed. Please contact your service provider for more details. (10)

growing prevalence of chronic diseases are the main factors contributing to the development of intravenous therapy and vein access devices market, globally. In addition, productive opportunity from emerging economies is the major trend observed in the market.

Download Sample Pages@ https://www.acumenresearchandconsulting.com/request-sample/504

Increasing Prevalence of Chronic Diseases to Have High Impact on Market

In the past few decades, cases of chronic diseases and

trauma have grown at an alarming rate and created the need for effective healthcare measures for treating such illnesses. According to World Health Organization, chronic diseases such as diabetes, cardiovascular disorders, cancer, and chronic respiratory diseases lead to around 70% of the total deaths globally. Intravenous therapies are beneficial in treating chronic diseases such as cancer, diabetes, pain management, and others, which require timely administration of drugs and therapeutics. Thus, most healthcare professionals are deploying infusion & injection therapies, as these are ideal for a successful prognosis. This is anticipated to boost the market growth in future.

Browse Full Report with Table Of Content, List of Table and Figures - https://www.acumenresearchandconsulting.com/intravenous-therapy-and-vein-access-devices-market

Insights on Market Segments

Global intravenous therapy and vein access devices market is segmented by product type, end user, and medical applications. Based on different product types, the market is segmented into implantable port, intravenous catheter, hypodermic needles, infusion pumps, and other products. Further, implantable port is sub-classified into single lumen implantable port and double lumen implantable port. Also, intravenous catheter is further sub-segmented into peripheral intravenous catheter, central intravenous catheter and peripherally inserted central catheter. The intravenous catheter segmented by product type is expected to maintain its dominance during the analysis period. Intravenous catheter is placed into vein to administer medication or fluids and can also be used to draw blood from the vein. This device plays an essential part in medical treatments for acute illness, cancer, surgery, trauma, and anesthesia. The medical application segment comprises volume expanders, medication administration, blood based products, nutrition and buffer solution. By end user, market is bifurcated into hospitals, ambulatory surgical centers, clinics.

Make an inquiry for purchasing this report@ https://www.acumenresearchandconsulting.com/inquiry-before-buying/504

North America Held Highest Market Share in 2016

The North America IV therapy and vein access devices market accounted for the highest market share of around 41% in 2016, and is expected to maintain this trend during the forecast period. This dominance of North America is attributed by rise in chronic diseases such as diabetes, ongoing trend of preventive healthcare, and increase in the number of trauma and road accident cases. According to the National Cancer Institute in the U.S., about 1,685,210 new cancer cases were diagnosed and 595,690 people died of cancer in 2016. Likewise, according to vital statistics issued by the Centre for Disease Control and Prevention (CDC), people who died from heart disease were 633,842, chronic respiratory disease were 155,041, diabetes were 79,535, and unintentional injury were 146,571, in the year 2015. Thus, growing occurrences of chronic illnesses is driving the growth of IV therapy and vein access devices market in North America.

Among the player operating in the global intravenous therapy and vein access devices market, some profiled in the report include AngioDynamics, Inc., B. Braun Melsungen AG, Medtronic Plc, Pfizer, Fresenius Medical Care, Becton, Dickinson And Company, Teleflex Incorporated, Terumo Medical Corporation, Insulet Corporation, and Smith & Nephew Plc. among others.

Buy this premium research report at https://www.acumenresearchandconsulting.com/buy-now/0/504

Would like to place an order or any question, please feel free to contact at sales@acumenresearchandconsulting.com 

About Us

Acumen Research and Consulting (ARC) is a global provider of market intelligence and consulting services to information technology, investment, telecommunication, manufacturing, and consumer technology markets. ARC helps investment communities, IT professionals, and business executives to make fact based decisions on technology purchases and develop firm growth strategies to sustain market competition. With the team size of 100+ Analysts and collective industry experience of more than 200 years, Acumen Research and Consulting assures to deliver a combination of industry knowledge along with global and country level expertise.

Contact:

Frank Wilson

Sales Manager | Acumen Research and Consulting

Email: frank@acumenresearchandconsulting.com 

Ph - USA +1 716-2400-831

Asia-Pacific +912065600384

Web: https://www.acumenresearchandconsulting.com/ 

Blog: http://pharmainvestmentnews.com/  

Blog: http://chemicalandmaterials.com/

Primary Logo




BiomedReports is not paid or compensated by newswires to disseminate or report news and developments about publicly traded companies, but may from time to time receive compensation for advertising, data, analytics and investor relation services from various entities and firms. Full disclosures should be read in the 'About Us Section'.

Add this page to your favorite Social Bookmarking websites
Digg! Reddit! Del.icio.us! Mixx! Google! Live! Facebook! Technorati! StumbleUpon! MySpace! Yahoo!
 

Newsletter

BMR:1